socalTECH

MARCH 28, 2019

San Diego-based biotech startup Biolinq , which is developing wireless-enabled biosensor patches for continuous monitoring of biomarkers, has raised $4.75M additional Series A funding, the company said this morning. According to the startup, the investment brings its Series A total funding to $15M. READ MORE>>.

Marketing 168

Marketing San Diego Venture Capital Study 168

Xconomy

MARCH 28, 2019

Biosensor startup Biolinq said Thursday it has raised $4.75 million from new investors, including the New York-based Juvenile Diabetes Research Foundation, following the results of a clinical study of its experimental biomarker monitoring device. The San Diego startup.

San Diego 103

San Diego Study Research Design 103

socalTECH

JUNE 24, 2019

San Diego-based biopharmaceuticals startup AFYX Therapeutics announced this morning that it has raised $13M in a convertible loan financing. The company is currently in an ongoing, Phase 2B study. The note came from Sofinnova Ventuers, which led the investment, and also included Nova Seeds and Lundbeckfonden Emerge.

Study 113

Study San Diego Platform Invest 113

Xconomy

DECEMBER 18, 2019

More than 250 miles above the Earth’s surface aboard the International Space Station, a first-in-kind study of neurodegenerative disease is expected to reveal never-before-seen cell interactions.

Research 90

Research San Diego Study Funding 90

socalTECH

OCTOBER 23, 2019

San Diego-based Intrepida Bio , a biopharmaceuticals startup focused on developing medicines that modulate the innate immune system to fight cancer and other diseases, has raised $9.5M in a funding round, according to the company. The funding came from Sofinnova Investments and Canaan. Intrepedia was co-founded by Joel F.

San Diego 100

San Diego Study Funding Invest 100

socalTECH

OCTOBER 1, 2018

San Diego-based VelosBio , a biotech startup developing novel antibody-drug conjugates to treat hematological cancers and solid tumours, has raised $58M in a funding round. The Series A funding was led by Arix Bioscience, and also included Pappas Ventures, Chiesi Ventures, Takeda Ventures, and Decheng Capital. READ MORE>>.

San Diego 113

San Diego Study Funding Capital 113

socalTECH

NOVEMBER 7, 2018

San Diego-based Mirium Pharmaceuticals , which is developing treatments for rare liver diseases, announced on Wednesday morning that it has raised $120M in a Series A funding round. The company says it recently had a successful Phase 2b study. READ MORE>>.

San Diego 147

San Diego Study Capital Funding 147

Xconomy

JULY 6, 2016

The Obama administration’s push to sign up one million Americans for a long-term health study will start in New York, Pittsburgh, Chicago, and Tucson, AZ, top health officials said today. The VA is running its own long-term study with nearly half a million participants so far.).

Study 59

Study PMI San Diego Sample 59

TechCrunch LA

SEPTEMBER 25, 2020

You can sign up here. Now, Microsoft-owned GitHub is gearing up to remove these references to slavery by naming primary code repositories “main” instead of “master.” Let’s start with Prop 22. A new poll from the UC Berkeley Institute of Governmental Studies found that it’s going to be a close election.

Capital 316

Capital Los Angeles News San Diego 316

Xconomy

DECEMBER 20, 2018

New biopharma company Aristea Therapeutics has raised $15 million from Novo Holdings, the Danish investment company, and secured global rights to an investigational AstraZeneca drug that’s ready for Phase 2 study. The San Diego, CA, company made its public debut this week after starting up quietly earlier this year.

Develop 67

Develop Development San Diego Study 67

Xconomy

FEBRUARY 26, 2020

About three years ago fledgling San Diego-based startup PvP Biologics announced a $35 million deal with Takeda Pharmaceutical that gave the Japan pharma giant rights to acquire the company down the line. The deal follows completion of a Phase 1 study evaluating the PvP drug. That day is here.

San Diego 72

San Diego Study Develop Development 72

Xconomy

OCTOBER 1, 2018

VelosBio, a biotech startup researching new cancer drugs, has raised $58 million in financing. VelosBio joined Johnson & Johnson’s JLABS @ San Diego incubator in January. The new VelosBio cash is earmarked for completing the work needed to proceed into human studies. The specific cancers that VelosBio.

San Diego 91

San Diego Incubator Class Study 91

Xconomy

APRIL 18, 2018

John Dobak, a life sciences serial entrepreneur in San Diego, said a new startup he’s leading has raised $2.66 The biotech, 10xBio, announced earlier this month that the FDA had approved its application to begin clinical trials in Phase 1b/2a studies testing the unnamed injectable drug.

San Diego 72

San Diego Study Entrepreneur Startup 72

socalTECH

FEBRUARY 9, 2011

The number of Southern California related initial public offerings is growing steadily upwards, as Gevo --originally started in Pasadena, and based on technology out of Caltech and UCLA--hit the market this morning. Gevo is just the latest in a surge of companies hitting the public markets which have Southern California links.

Southern California 200

Southern California Westlake Village Woodland Hills Beverly Hills 200

Xconomy

APRIL 11, 2017

As part of the financing, Kalamazoo-based Octeta Therapeutics has been rechristened Cirius Therapeutics, and three San Diego-based biotech executives are stepping into key executive roles. All three were former Laguna Pharmaceuticals executives who spent the past 16 months scouting for Frazier as entrepreneurs-in-residence.

Study 55

Study San Diego Entrepreneur Venture Capital 55

Xconomy

NOVEMBER 27, 2018

Roche is acquiring San Diego startup Jecure Therapeutics, with hopes of turning Jecure’s early research into a drug or drugs that treat the liver disease NASH.

San Diego 67

San Diego Study Research Organization 67

socalTECH

APRIL 15, 2019

San Diego-based Wheels (www.takewheels.com) was co-founded by Jon and Josh Viner, who were the co-founders of Wag, where they raised nearly $400M in venture capital. Wheels currently operates in Los Angeles and San Diego. Josh Viner: Wheels is live in Los Angeles and San Diego. What is Wheels?

San Diego 113

San Diego Startup Study Los Angeles 113

Xconomy

NOVEMBER 2, 2018

The gene-editing technology CRISPR-Cas9 is opening up new research avenues all the time, such as giving drug developers a cheaper, faster way to knock out genes in tumor cells. Studies of CRISPR-Cas9 to treat human disease are about to start, too. This week, we reported on a new study that raises exactly that question.

Study 74

Study Startup Research Report 74

Xconomy

SEPTEMBER 25, 2017

After launching a study to identify how tech hubs work, the leader of a nonprofit consortium created to boost Southern California’s startup ecosystem says he is focusing on three initiatives to supercharge the seven-county SoCal region as a hotbed for innovation. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Southern California 61

Southern California San Diego SoCal Incubator 61

Xconomy

NOVEMBER 3, 2017

Plante is a technology industry veteran in San Diego who has served as the CEO of Bel-Tronics, and as the founding CEO of SmartDrive Systems and Pathway Genomics. Studies in mice have. Thynk Capital founder and principal Jim Plante also is Klotho’s founder and CEO.

San Diego 85

San Diego Study Capital Technology 85

socalTECH

AUGUST 2, 2013

How do you keep up with everything that''s happening with your favorite interests, brands, and personalities on your mobile phone? We caught up with CEO Phil Kelly to better understand what the company is working on. How did the company start? Phil Kelly: I started the company early last year. Or, you can go to Yapert.

Mobile 159

Mobile Startup Entertainment Tech Coast Angels 159

Xconomy

FEBRUARY 15, 2017

For these reasons, fatty liver disease is often called a “silent disease,” says Ariel Feldstein, a gastroenterologist at the University of California San Diego. Feldstein has been studying the liver for nearly 20 years, and his research now forms the basis of a newly launched company called Jecure Therapeutics.

UCSD 64

UCSD Press San Diego Class 64

Xconomy

AUGUST 11, 2016

government has ambitious plans for a long-term health study with one million Americans, and one of the world’s most powerful tech companies has a big part to play, including the storage of all the data on its “cloud” servers. Vanderbilt had a head start stumping for it.

PMI 40

PMI Study Google Research 40

Xconomy

AUGUST 22, 2016

In downtown San Diego, a private real estate company best known for its master-planned communities in suburban Southern California has posed some existential questions for regional tech hubs looking to build their own startup ecosystems. 101 West Broadway tower in downtown San Diego.

Develop 40

Develop Development San Diego Startup 40

Xconomy

FEBRUARY 15, 2017

At the UC San Diego Design Lab , director Don Norman talks about the importance of studying and understanding how people are actually using something—whether it is a computerized interface or a door handle. Here at Xconomy, we are gathering prominent scientists, executives, investors, and others in San Diego.

San Diego 64

San Diego Design Study Ideas 64

Xconomy

MAY 25, 2017

volunteers and amass a treasure trove of their health information will start next week with a “beta test” that health officials hope to eventually expand nationwide. An ambitious plan to recruit 1 million U.S. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Study 81

Study Startup San Diego Conference 81

socalTECH

FEBRUARY 3, 2012

How do you come up with a compelling, mobile videogame title? We thought it would be interesting to hear the story behind Jonathan's startup efforts and where he hopes his mobile gaming startup will go. When we started the company, we wanted to make it the next generation, social video game developer. What is Playzon?

Startup 217

Startup Mobile Venture Capital Resource 217

Xconomy

OCTOBER 22, 2018

Early next year, twenty students will have the opportunity to study machine learning for 10 weeks with Google engineers, college professors, and coaches—free of charge.

Course 94

Course Artificial Inteligence Google Coach 94

Xconomy

DECEMBER 7, 2017

Proceeds will be used to advance Metacrine’s lead drug candidate, MET409, into first-in-human studies during the first half of 2018. Initial studies should be completed by the end of the year, the San Diego-based company said.

San Diego 49

San Diego Study Develop Development 49

Xconomy

AUGUST 1, 2017

Ciara Kennedy, who succeeded Mike Grey as Amplyx CEO late last year, said in an interview with Xconomy that the company plans to report results of its Phase 1 study at IDWeek, the annual infectious diseases conference that is set for early October in San Diego. But raising $67.

San Diego 67

San Diego Study Conference Report 67

Xconomy

SEPTEMBER 27, 2016

Fortis Therapeutics, a new San Diego biotech, has raised $18 million in initial funding to develop drugs for hard-to-treat prostate and bone marrow cancers. San Diego’s Avalon Ventures led the Series A round, and has established Fortis at COI Pharma, the firm’s biotech incubator (which now houses 16 life sciences startups).

Avalon 40

Avalon Funding Startup San Diego 40

socalTECH

APRIL 11, 2013

One of the companies which has been helping to power that revolution is TakeLessons (www.takelessons.com), a San Diego company which helps music teachers find students, both for in-person lessons as well as for online teaching sessions. We caught up with Steven Cox , the company''s CEO, to learn more about the company.

Startup 260

Startup Education Study Ideas 260

socalTECH

JUNE 21, 2013

The San Diego firm is headed by Ethan Senturia , who sat down with us to tell us how Dealstruck is trying to help build small businesses and jobs--and also tells us a bit about what it''s like to come from a family full of very successful, and high profile entrepreneurs, and how that has influenced his experience as an entrepreneur himself.

Startup 247

Startup Software Review Entrepreneur Equity 247

Xconomy

MAY 30, 2016

Lita Nelsen has seen it up close—and played a part in its evolution—from her studies there in the 1960s, to her business-school fellowship in the late 1970s, to her 30 years working in MIT’s Technology Licensing Office. And so that’s what Stanford did, so it was set up in that model. That meant we were licensing.

Startup 67

Startup Compton Research Technology 67

Xconomy

MARCH 2, 2017

Time is running out to secure the $99 super saver discount for The Xconomy Forum on Human Impact of Innovation on April 19 in San Diego. There has been a lot of talk around the importance of studying and understanding how people use something—and we are bringing this idea front and center.

San Diego 40

San Diego Study Ideas Artificial Inteligence 40

Xconomy

JUNE 21, 2018

The San Francisco company priced its IPO late Tuesday, selling 6.25 Eidos will use the cash to fund studies of AG10 , a drug in mid-stage testing for transthyretin (TTR) amyloidosis, a progressive and fatal condition caused by the. million shares at $17 each, which was on the high end of its projected $15 to $17 range.

Study 72

Study Startup Pricing Funding 72

Xconomy

JULY 20, 2016

First came Inception Sciences , a holding company for spinning out biotech startups established by Versant Ventures and Peppi Prasit, the veteran San Diego drug developer. All of the company’s funding so far has come from Sofinnova Ventures, and Mike Powell, a Sofinnova general partner in San Francisco, is board chairman.

San Diego 40

San Diego Avalon Outsource Development Newsletter 40